Content moderation compliance
Content moderation compliance in Healthcare & Life Sciences has moved from a peripheral concern to an operational requirement, driven by the U.S. Food and Drug Administration's accelerating enforcement posture on digital health content and the Federal Trade Commission's 2023 Health Breach Notification Rule expansion covering platforms that surface user-generated health claims. The European Medicines Agency has added pressure for multinational organizations by tightening guidance on how promotional and patient-generated content must be reviewed before it reaches consumers. Compliance teams are currently mapping social media moderation policies and third-party platform contracts against these overlapping standards to avoid simultaneous regulatory exposure on both sides of the Atlantic.
Watch
- FTC Health Breach Notification Rule: which digital health platforms now fall in scope
- FDA draft guidance on prescription drug promotion via social media, pending finalization
- EMA patient content rules intersecting with U.S. adverse event reporting obligations
- State attorneys general actions targeting misleading health claims on provider-run platforms
Recent material activity in Healthcare & Life Sciences
Active monitoring in place across Healthcare & Life Sciences. Material developments related to content moderation compliance will appear here as they are published.